| Active substance |
Pregabalin |
| Also known as |
Lyrica |
| Blood pressure |
Typically has minimal impact on blood pressure |
| Chemical name |
(3S)-3-(aminomethyl)-5-methylhexanoic acid |
| Classification |
Anticonvulsants |
| Dosage (medical) |
Typically starts at 150 mg per day, divided into 2-3 doses, and can be increased to a maximum of 600 mg per day |
| Dosage (sports) |
Not applicable as it is not typically used for performance enhancement |
| Effects |
Analgesic, anticonvulsant, and anxiolytic effects |
| Formula |
C8H17NO2 |
| Half-life |
6.3 hours |
| Hepatotoxicity |
Low |
| Lab Test |
Detection involves specific analytical techniques like gas chromatography-mass spectrometry (GC-MS) |
| Main action |
Reduces the release of several neurotransmitters, including glutamate, norepinephrine, and substance P |
| Side effects |
Dizziness, sleepiness, dry mouth, and blurred vision |
| Storage conditions |
Store at room temperature, away from light and moisture |
| Substance class |
Gabapentinoid |
| Trade name |
Lyrica |
| Use in sports |
Not commonly used in sports, lacks performance-enhancing properties |
| WAREHOUSE |
International Warehouse 1 |
| Water Retention |
Minimal |
| Manufacturer |
Signature |
